The managing director of Safeguard Scientifics (NYSE: SFE) life sciences portfolio, Jim Datin, has taken over management of the technology portfolio in what was described as a strategic move by the venture capital firm reflecting the acceleration of health IT and medical devices with technology components. Kevin Kemmerer, who led the firm’s technology portfolio, resigned, effective immediately according to an SEC filing dated October 24.
It was agreed that the resignation will be treated as having been for “good reason,” as defined in Kemmerer’s agreement with the company dated December 29, 2008, the statement said.
To read the full, original article click on this link: Safeguard Scientifics consolidates life science, tech portfolio management
